TITLE

Savient Shares Tumble on Extension Safety Data

PUB. DATE
November 2008
SOURCE
Bioworld Week;11/3/2008, Vol. 16 Issue 44, p3
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the decrease in the shares of Savient Pharmaceuticals Inc. following the company's presentation of data on its pegloticase (Puricase) for treatment-resistant gout in the U.S. Analysts' main concerns are the safety issue of the drug and the size of its market. The company claims that the drug has an acceptable safety and tolerability profile.
ACCESSION #
35064701

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics